Option Care Health (OPCH) Projected to Post Earnings on Tuesday

Option Care Health (NASDAQ:OPCH) is anticipated to issue its Q4 2025 results before the market opens on Tuesday, February 24th. Analysts expect the company to announce earnings of $0.46 per share and revenue of $1.4633 billion for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Tuesday, February 24, 2026 at 8:30 AM ET.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH opened at $35.42 on Tuesday. The business has a fifty day moving average of $33.71 and a 200-day moving average of $30.21. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.05 and a current ratio of 1.56. Option Care Health has a twelve month low of $24.24 and a twelve month high of $36.80. The firm has a market cap of $5.62 billion, a PE ratio of 28.11, a price-to-earnings-growth ratio of 2.11 and a beta of 0.84.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on OPCH shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. Bank of America boosted their price objective on shares of Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a research report on Tuesday, December 9th. Citizens Jmp reiterated a “market outperform” rating and issued a $38.00 price objective (up from $36.00) on shares of Option Care Health in a research report on Tuesday, January 13th. Morgan Stanley boosted their target price on Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 13th. Finally, National Bank Financial set a $37.00 price target on Option Care Health in a research note on Tuesday, January 27th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $37.46.

Institutional Trading of Option Care Health

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Advisory Services Network LLC bought a new position in Option Care Health during the 3rd quarter worth approximately $35,000. McIlrath & Eck LLC acquired a new stake in Option Care Health in the second quarter worth $37,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Option Care Health during the third quarter worth $38,000. Quarry LP boosted its position in shares of Option Care Health by 502.7% during the third quarter. Quarry LP now owns 1,549 shares of the company’s stock worth $43,000 after purchasing an additional 1,292 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after buying an additional 1,183 shares during the period. 98.05% of the stock is owned by institutional investors.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.